Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Bactiguard Holding AB ( ($SE:BACTI.B) ) has issued an update.
At Bactiguard Holding AB’s Annual General Meeting, it was decided that no dividend will be paid for the financial year 2024, with retained earnings carried forward. The Board of Directors and CEOs were discharged from liability, and remuneration was set for the board members. Key board members, including Thomas von Koch as Chairman, were re-elected, and Deloitte AB was re-elected as auditor. The AGM also authorized the Board to issue new shares, warrants, and convertibles, which could impact the company’s financial strategy and shareholder value.
The most recent analyst rating on ($SE:BACTI.B) stock is a Hold with a SEK30.00 price target. To see the full list of analyst forecasts on Bactiguard Holding AB stock, see the SE:BACTI.B Stock Forecast page.
More about Bactiguard Holding AB
Bactiguard is a global MedTech company specializing in developing biocompatible technology to prevent infections related to medical devices. Their unique technology involves a noble metal coating that reduces bacterial adhesion and biofilm formation. The company focuses on infection prevention across five therapeutic areas: Orthopedics, Cardiology, Neurology, Urology, and Vascular Access. Bactiguard partners with leading MedTech companies to license their technology and also offers a range of wound management products. Their solutions aim to reduce patient suffering, save lives, and combat antimicrobial resistance. Bactiguard is headquartered in Stockholm, listed on Nasdaq Stockholm, and part of the Mid-Cap segment.
Average Trading Volume: 5,234
Current Market Cap: SEK1.09B
Find detailed analytics on BACTI.B stock on TipRanks’ Stock Analysis page.